Page last updated: 2024-10-27

gentamicin and Carcinoma, Transitional Cell

gentamicin has been researched along with Carcinoma, Transitional Cell in 1 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research Excerpts

ExcerptRelevanceReference
"Cystitis was the most common side effect, being seen to some degree in all patients, although only forcing cessation of BCG therapy in two patients."1.30Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment. ( Patel, A; Paterson, DL, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paterson, DL1
Patel, A1

Other Studies

1 other study available for gentamicin and Carcinoma, Transitional Cell

ArticleYear
Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment.
    The Australian and New Zealand journal of surgery, 1998, Volume: 68, Issue:5

    Topics: Administration, Intravesical; Aged; Aged, 80 and over; Amoxicillin; Antitubercular Agents; BCG Vacci

1998